Your Opinion About Long-Acting PrEP: Fortune Effiong, Nigeria | IAS 2025
We asked people attending the International AIDS Society meeting in Kigali, Rwanda, their opinion about long-acting injectable HIV preexposure prophylaxis and what it could mean for HIV prevention. Fortune Effiong, a researcher at the University of Calabar Teaching Hospital in Nigeria, shared his views about the potential of self-injectable versions of PrEP.
Sexual Health and HIV Care Integration Key to Better Care | IAS 2025
July 14th 2025Integrating HIV and sexual health care is essential for improving outcomes, but global stigma, funding cuts—especially the defunding of USAID—and structural barriers like limited access and political resistance continue to hinder progress, experts emphasized at IAS 2025.
Read More
Black Women Can Successfully Be Started on Long-Acting Apretude for HIV PrEP | IAS 2025
July 14th 2025Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in various clinics but also providing more flexible scheduling and partnering with specialty pharmacies.
Read More
